SCHEMBL6351791

SCHEMBL6351791

CCCCc1c2ccccc2nc2c1c(C)nn2-c1ccccn1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 7/20 0.47
KDM4E B2RXH2 6/20 0.47
MAPT P10636 5/20 0.47
HPGD P15428 3/20 0.47
NPSR1 Q6W5P4 2/20 0.47
GAA P10253 2/20 0.47
HTT P42858 2/20 0.47
TSHR P16473 3/20 0.46
CYP1A2 P05177 1/20 0.46
CYP3A4 P08684 1/20 0.46
HSD17B10 Q99714 1/20 0.46
USP2 O75604 1/20 0.43
LMNA P02545 3/20 0.41
KMT2A Q03164 3/20 0.41
MEN1 O00255 2/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
POLB P06746 1/20 0.40
ALOX15 P16050 1/20 0.40
XBP1 P17861 1/20 0.40
MAPK1 P28482 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6344781 0.97 KDM4E (0.46) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6343111 0.94 KDM4E (0.48) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6351683 0.91 ALDH1A1 (0.50) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6344476 0.84 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6344384 0.84 ALDH1A1 (0.45) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6343768 0.84 SLC2A1 (0.46) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6343975 0.82 KDM4E (0.43) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6345998 0.82 ALDH1A1 (0.47) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6351852 0.81 ALDH1A1 (0.48) ALDH1A1KDM4EMAPTHPGDNPSR1
SCHEMBL6343952 0.81 ALDH1A1 (0.53) ALDH1A1KDM4EMAPTHPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6949648-B2 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2005-09-27 US disclosed
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2003-10-02 US disclosed
EP-1270572-A1 CONDENSED PYRAZOLE DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND USE THEREOF TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2003-01-02 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030187014-A1 Condensed pyrazole derivatives, process for producing the same and use thereof PTGS1, PTGIS, IL5 ALDH1A1 1061/4885KDM4E 1741/4885MAPT 3408/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.